ARCHIVES

Drugs and Targets: EU approves Imbruvica in MCL, CLL

This article is from The Cancer Letter archive.

Vol. 40 No. 40 | October 24, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Awards $59M Contract For Key Project To consolidate Phase III Trial Administration

October 29, 1999

DeVita Alert Advises That Negative Node Breast Cancer Patients Do Better With Adjuvant Therapy

May 27, 1988

Waksals Keep ImClone Jobs, BMS Pumps $200M Into C225

March 8, 2002

Preclinical Models: NCI Advisors OK Plan For Mouse Models Consortium

March 13, 1998

Interim Results Show Vaccine Lowers Breast Cancer Recurrence

December 30, 2011

In Brief: Healy Names President, CEO of Red Cross; AMA Supports annual Mammograms for 40+

July 16, 1999